Cell Behavior and Signal Molecule Involvement in a Case Study of Malignant Histiocytosis: A Negative Model of Morphine as an Immunoregulator

American Journal of Hematology

Volumn 56, Issue 4, 1997, Pages 197-205

  Fricchione, Gregory L ^a,b   Cytryn, Lawrence ^c   Bilfinger, Thomas V ^b,c   Stefano, George B ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Granulocytes; Medullary reticulosis; Monocytes; Morphine; Mu3

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; COLONY STIMULATING FACTOR 1; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; MORPHINE; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; BLOOD; CASE REPORT; CELL CULTURE; CHEMOTAXIS; DRUG EFFECT; FATALITY; GRANULOCYTE; HUMAN; IMMUNOLOGY; MALE; MALIGNANT HISTIOCYTOSIS; METABOLISM; MONOCYTE; PATHOLOGY; SIGNAL TRANSDUCTION;

AGED; ANALGESICS, OPIOID; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; CHEMOTAXIS; CYCLOPHOSPHAMIDE; CYTOKINES; DOXORUBICIN; FATAL OUTCOME; GRANULOCYTES; HISTIOCYTOSIS, MALIGNANT; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MONOCYTES; MORPHINE; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 0031434786     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199712)56:4<197::AID-AJH1>3.0.CO;2-S     Document Type: Article

References (37)

1. Bodley SR, Smith R: Histiocytic medullary reticulosis. Lancet ii:194, 1939.
2. Rappaport H: Tumors of the hemopoietic system. In Rappaport H (ed): "Atlas of Tumor Pathology." Washington, DC: Armed Forces Institute of Pathology, 1966, pp 48-88.
3. Cline MJ: Histiocytes and histiocytosis. Blood 84:2840, 1994.
4. Siegert W, Nell C, Engelhard M, Brittinger G, Tiemann M, Parwaresch R, Heinz R, Huhn D: Peripheral T-cell non Hodgkin's lymphomas of low malignancy: Prospective study of 25 patients with pleomorphic small cell lymphoma lymphoepithelial cell (Lehnert's) lymphoma and T-zone lymphoma. The Kiel lymphoma study group. Br J Hematol 87:529, 1994.
5. Editorial: Trends in lymphoma diagnosis. Lancet 1:249, 1989.
6. Nezlof C: The 5q35bp chromosomal abnormality characterizes certain CD30 positive anaplastic large cell lymphomas offering a new definition of malignant histiocytosis in childhood. Nouv Rev Fr Hematol 35:463, 1993.
7. Ishii E, Ohga S, Aoki T: Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor. Acta Haematol 85:93, 1991.
8. Stefano GB: Role of opioid neuropeptides in immunoregulation. Prog Neurobiol 33:149, 1989.
9. Stefano GB, Melchiorri P, Negri L, Hughes TK, Scharrer B: (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA 89:9316, 1992.
10. Stefano GB, Digenis A, Spector S, Leung MK, Bilfinger TV, Makman MH, Scharrer B, Abumrad N: Opiatelike substances in an invertebrate, a novel opiate receptor on invertebrate and human immunocytes, and a role in imnuinosuppression. Proc Natl Acad Sci USA 90:11099, 1993.
11. Smith EM, Hughes TKJ, Hashemi F, Stefano GB: Immunosuppressive effects of ACTH and MSH and their possible significance in human immunodeficiency virus infection. Proc Natl Acad Sci USA 89:782, 1992.
12. Stefano GB, Bilfinger TV, Fricchione GL: The immune-neuro link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 42:475, 1994.
13. Fricchione GL, Bilfinger TV, Stefano GB: The macrophage and neuropsychiatric disorders. Neuropsychiatry, neuropsychology and behavioral neurobiology. Neurobiology 9:16, 1996.
14. Shipp MA, Stefano GB, D'Adamio L, Switzer SN, Howard FD, Sinisterra JI, Scharrer B, Reinkerz E: Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 347:394, 1990.
15. Stefano GB, Bilfinger TV: Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: Loss of DAME and IL-1 chemotaxis. J Neuroimmunol 47:189, 1993.
16. Stefano GB, Paemen LR, Hughes TKJ: Autoimmunoregulation: Differential modulation of CD10/neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides. J Neuroimmunol 41:9, 1992.
17. Stefano GB, Kushnerik V, Rodriquez M, Bilfinger TV: Inhibitory effect of morphine on granulocyte stimulation by tumor necrosis factor and substance p. Int J Immunopharmacol 16:329, 1994.
18. Stefano GB, Rodriquez M, Glass R, Casares F, Hughes TKJ, Bilfinger TV: Hyperstimulation of leukocytes by plasma obtained from cardiopulmonary bypass patients is diminished by morphine and IL-10 pretreatment. J Cardiovasc Surg 36:25, 1995.
19. Makman MH, Bilfinger TV, Stefano GB: Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol 154:1323, 1995.
20. Stefano GB, Smith EM, Cadet P, Hughes TKJ: HIV GP120 alteration of DAMA and IL-1a induced chemotaxis responses in human and invertebrate immunocytes. J Neuroimmunol 43:177, 1993.
21. Levy R, Dana R, Gold B, Alkan M, Schlaeffer F: Influence of calcium channel blockers on polymorphonuclear and monocyte bactericidal and fungicidal activity. Israel J Med Sci 27:301, 1991.
22. Herrmann F, Mertelsmann R: Regulatory effects of cytokines on myelopoiesis. In Coffey RR (ed): "Granulocyte Responses to Cytokines." New York: Marcel Dekker, Inc., 1992, pp 339-349.
23. Donahue RE, Clark SC: Granulocyte colony stimulating factors as therapeutic agents. In Coffey RR (ed): "Granulocyte Responses to Cytokines." New York: Marcell Dekker, Inc., 1992, pp 637-649.
24. Axelrad AA: Some hemopoietic negative regulators. Exp Hematol 18:143, 1990.
25. Adams DO, Hamilton TA: Molecular basis of macrophage activation: Diversity and its origins. In Lewis C (ed): The Natural Immune System." Oxford: University of Oxford Press, 1992, pp 1020-1026.
26. Adams DO: Macrophage activation. In Roitt IM, Delves PJ, (eds): "Encyclopedia of Immunology," Philadelphia: W.B. Saunders, 1992, pp 1020-1026.
27. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB: Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 156:4845, 1996.
28. Stefano GB, Scharrer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 4:57, 1994.
29. Oka K, Mori N, Yatabe Y, Kojima M: Malignant hisitocytosis. A report of 3 cases. Arch Pathol Lab Med 116:1228, 1992.
30. Nathan CF: Secretory products of macrophages. J Clin Invest 79:319, 1987.
31. Reiner AP, Spivak JL: Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine 67:369, 1988.
32. Risdall RJ, McKenna RW, Nesbit ME, Drivit W, Balfrow HHJ, Simmons RL, Bunning RD: Virus associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993, 1979.
33. Wong KF, Chan JK: Reactive hemophagocytic syndrome. A clinicopathological study of 40 patients in an Oriental population. Am J Med 93:177, 1992.
34. Jaffe ES, CostaFauci AS, Cossman J, Isokos M: Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 304:648, 1981.
35. Su IJ, Hsu YH, Lin MT, Cheng AL, Wang CH, Weiss LM: Epstein-Barr virus containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer 72:2019, 1993.
36. Muller-Hermelink HK: Epstein-Barr virus, β-cells, T-cells, and a lymphoproliferative disorder. Lancet 343:922, 1994.
37. Ohshima K, Fujisaki T, Nagafudii S, Niho Y, Koloari S, Kikudii M: Malignant histiocytosis derived from a common histiocyte clone in a patient with chronic Epstein Barr virus infection. Leuk Lymph 17:355, 1995.